)
NEWS
Media Contacts:
Seqirus news releases
Seqirus news releases
Seqirus opens new Italian headquarters
Seqirus, a global leader in influenza prevention, today opened its new Italian headquarters in San Martino, Monteriggioni, just outside Siena.
Anjana Narain to Lead Seqirus Influenza Vaccines Business
CSL Limited today named Anjana Narain, a seasoned leader in vaccines and biopharmaceuticals, as Executive Vice President and General Manager of its Seqirus business, one of the world’s largest influenza vaccines providers.
Seqirus is First-to-Market with U.S. 2019/20 Influenza Vaccines
This news release is intended for business and trade media only.
First cell-based quadrivalent influenza vaccine approved for use in Europe
This news release is intended for Health Professional media only.
Seqirus Announces U.S. $140 Million Manufacturing Expansion to Meet Growing Demand for Innovative Cell-Based Influenza Vaccines
The expansion will allow Seqirus to increase capacity for formulation, fill and finish manufacturing of cell-based and adjuvanted influenza vaccines for global markets.
New Data on Cell-Based Seasonal Influenza Vaccines
This news release is intended for Health Professional media only.